Latest news
How do vaccine conspiracy beliefs develop?
Researchers analyzed five years of longitudinal panel survey data collected between 2020 and 2024 and examined how vaccine-related conspiracy beliefs were associated with media skepticism during the COVID-19 pandemic.
Does eczema increase the risk of developing shingles?
New research indicates that people with eczema face an elevated risk of developing shingles.
Lemurs fall prey to human herpes virus
A new study marks the first time researchers have been able to confirm human herpesvirus in lemurs via a molecular analysis, outlining the cases of four privately owned animals who died from the illness.
Biofortified millet benefits toddlers without supplement side effects
Toddlers who ate iron- and zinc-biofortified pearl millet for nine months did not experience adverse effects typically associated with increased iron intake and developed gut microbiomes with distinct and potentially beneficial changes.
First immune pathway discovered that stops a normally harmless fungus spreading through the body and causing deadly disease
An immune pathway has been discovered which prevents a normally harmless fungus developing into a fatal infection.
Researchers visualise underground fungal networks in 3D
Researchers have visualized the complex network of plant roots and mycorrhizal fungi in soil in three dimensions for the first time.
How do vaccine conspiracy beliefs develop?
Researchers analyzed five years of longitudinal panel survey data collected between 2020 and 2024 and examined how vaccine-related conspiracy beliefs were associated with media skepticism during the COVID-19 pandemic.
Does eczema increase the risk of developing shingles?
New research indicates that people with eczema face an elevated risk of developing shingles.
Lemurs fall prey to human herpes virus
A new study marks the first time researchers have been able to confirm human herpesvirus in lemurs via a molecular analysis, outlining the cases of four privately owned animals who died from the illness.
ABM strengthens Irish life sciences business with major multi-site life sciences contract
ABM, a leading international provider of facility, engineering, and infrastructure solutions, has secured a major multi-site services agreement with a leading global life sciences company operating manufacturing facilities across Ireland.
Bruke showcases expanding Microbiology & Infection Diagnostics portfolio at ASM Microbe 2026
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
Researchers visualise underground fungal networks in 3D
Researchers have visualized the complex network of plant roots and mycorrhizal fungi in soil in three dimensions for the first time.
UBC seaweed-derived coating keeps strawberries fresher than a fridge
A new agar-based coating could help cut spoilage, food waste and reliance on refrigeration.
A tiny pore identifies cyanobacteria toxins in lake water
Scientists have developed a new nanopore sensor that detects microcystins, toxins released by cyanobacterial blooms, one molecule at a time.
Free webinar: The secret world of the vaginal microbiome
A fascinating free webinar will shine a light into the secret world of the human microbiome and how it influences gynecological health. It will focus on what the vaginal microbiome can reveal about health, disease, and the gaps in care we still need to address.
Scientists bring Florida high school students to the front lines of pandemic preparedness
Thirty outstanding high school students from 18 communities across Florida arrived in Tampa last week for the Global Virus Network (GVN) Global Guardians for Pandemic Preparedness Program, curious about viruses and considering careers in science.
Leishmania: When tropical parasites use immune cells as a taxi
Tom Beneke intends to clarify, as part of the new Emmy Noether Research Group ‘LeishMove’, exactly how the Leishmania parasites control their host cells and which variations in the parasites are necessary for this.